SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	Jun 22, 2023	View HTML 0001562180-23-005446.pdf 0001562180-23-005446.rtf 0001562180-23-005446.xls
4	Statement of changes in beneficial ownership of securities	Jun 22, 2023	View HTML 0001562180-23-005450.pdf 0001562180-23-005450.rtf 0001562180-23-005450.xls
4	Statement of changes in beneficial ownership of securities	Jun 22, 2023	View HTML 0001562180-23-005451.pdf 0001562180-23-005451.rtf 0001562180-23-005451.xls
8-K	Report of unscheduled material events or corporate event	Jun 21, 2023	View HTML 0000950170-23-029066.pdf 0000950170-23-029066.rtf 0000950170-23-029066.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	Jun 05, 2023	View HTML 0000950170-23-026230.pdf 0000950170-23-026230.rtf 0000950170-23-026230.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
4	Statement of changes in beneficial ownership of securities	May 31, 2023	View HTML 0001562180-23-004632.pdf 0001562180-23-004632.rtf 0001562180-23-004632.xls
4	Statement of changes in beneficial ownership of securities	May 30, 2023	View HTML 0001562180-23-004580.pdf 0001562180-23-004580.rtf 0001562180-23-004580.xls
4	Statement of changes in beneficial ownership of securities	May 30, 2023	View HTML 0001562180-23-004579.pdf 0001562180-23-004579.rtf 0001562180-23-004579.xls
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	May 26, 2023	View HTML 0001968940-23-000001.pdf 0001968940-23-000001.rtf
144/A	Amendment to a previously filed 144	May 26, 2023	View HTML 0001840315-23-000004.pdf 0001840315-23-000004.rtf 0001840315-23-000004.xls

Data provided by Kaleidoscope.